Akobo Minerals Secures International Funding for its Ethiopian Gold Mine Project

Akobo Minerals AB (Euronext Oslo – ticker “AKOBO”), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announced with reference to the stock exchange announcement of 10 August 2022, that it has successfully secured a US$ 8.5 million gold loan facility from US based Monetary Metals.

Image Credit: Akobo Minerals

The net proceeds from the loan facility, secured through its wholly-owned subsidiary, Abyssinia Resources Development AS, will ensure that Akobo Minerals has the financial strength to accelerate the final phase of its mine development at Segele. Gold production is on-track to commence in early 2023.

Jørgen Evjen, CEO of Akobo Minerals, stated: “This financing agreement with Monetary Metals gives Akobo Minerals exactly what we were looking for – a loan facility that will take us through to completion of our mine and the start of gold production, while at the same time ensuring a minimal dilution of equity for our shareholders. We can now look forward to mining and production in the new year with renewed confidence. 

“Furthermore, the deal with Monetary Metals shows a strong international endorsement of our gold exploration and mining project in Ethiopia. We have greatly enjoyed working with them through the process, which included taking them on a site visit to Segele to show them our developing mining operation.” 

Keith Weiner, CEO of Monetary Metals, said: “Jørgen and Akobo’s management team presented us with a professional approach to running the business. Couple that with a remarkable gold deposit at Segele, and you have a very compelling economic proposition.”

The loan facility is structured as a gold loan, whereby Akobo Minerals borrows the principal amount of 5.000 ounces of gold, paid out in US$. The loan can be repaid in gold or the equivalent US$ cash amount using the applicable gold price at the time of repayment. As the loan is pegged to the gold price and also the value of the gold in the Segele deposit, it provides a natural hedge to gold price fluctuations.

The loan facility has a two-year maturity, with an annual interest rate of 22 percent. There are additional provisions regulating early repayment, which also includes a cash sweep of 50 percent of quarterly free cash flow. It is not expected that there will be any cash sweep before the second quarter of 2023. As compensation for arranging the loan facility, Monetary Metals will also be awarded warrants equal to two percent of Akobo’s equity, with a strike price of NOK 6.9 per share. 

SpareBank 1 Markets is acting as financial advisor to Akobo Minerals in relation to the project financing, while Advokatfirmaet Schjødt is acting as legal advisor.

Source: https://akobominerals.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Akobo Minerals AB. (2022, November 10). Akobo Minerals Secures International Funding for its Ethiopian Gold Mine Project. AZoMining. Retrieved on April 25, 2024 from https://www.azomining.com/News.aspx?newsID=17195.

  • MLA

    Akobo Minerals AB. "Akobo Minerals Secures International Funding for its Ethiopian Gold Mine Project". AZoMining. 25 April 2024. <https://www.azomining.com/News.aspx?newsID=17195>.

  • Chicago

    Akobo Minerals AB. "Akobo Minerals Secures International Funding for its Ethiopian Gold Mine Project". AZoMining. https://www.azomining.com/News.aspx?newsID=17195. (accessed April 25, 2024).

  • Harvard

    Akobo Minerals AB. 2022. Akobo Minerals Secures International Funding for its Ethiopian Gold Mine Project. AZoMining, viewed 25 April 2024, https://www.azomining.com/News.aspx?newsID=17195.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.